Sustained, complete response to pexidartinib in a patient with CSF1R‐mutated Erdheim–Chester disease

Corresponding Author

Gaurav Goyal

Division of Hematology-Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA

Research Collaborator (Limited-Tenure), Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA

Correspondence

Gaurav Goyal, Division of Hematology-Oncology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

Email: ggoyal@uabmc.edu

Ronald S. Go, Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA.

Email: go.ronald@mayo.edu

Search for more papers by this author

留言 (0)

沒有登入
gif